Stock NEPH NEPHROS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Nephros, Inc.

Equities

NEPH

US6406714005

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
2.2 USD -5.58% Intraday chart for Nephros, Inc. +0.46% -36.42%
03-07 Transcript : Nephros, Inc., Q4 2023 Earnings Call, Mar 07, 2024
03-07 Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
B. Riley Securities Lowers Nephros' Price Target to $4.25 from $5.25 Ahead of Q3 Results, Lowers Estimates; Maintains Buy Rating
MT
Benchmark Capital Downgrades Nephros to Hold From Speculative Buy
MT
B. Riley Lowers Nephros' Price Target to $5.25 from $8 After Lower-than-Expected Q1 Revenue, Keeps Buy Rating
MT
B. Riley Lowers Nephros' Price Target to $8 from $11.25, Lowers 2022 Estimates to Align with Management's Guidance; Maintains Buy Rating
MT
NEPHROS : B. Riley Starts Nephros at Buy With $12.50 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEPH Stock
  4. News Nephros, Inc.
  5. Analyst Reco.